Skip to main content
. 2020 Sep 18;25(18):4279. doi: 10.3390/molecules25184279

Figure 2.

Figure 2

Cross-talk between EGFR, VEGFR, and c-Met signalling pathways; in boxes are reported some quinoline based inhibitors developed up to date.